Regeneron, Mylan, and Biocon Settle in Aflibercept BPCIA Litigation
By EsqSocial Corporation 29/04/25
On April 22, 2025, the U.S. District Court for the Northern District of West Virginia entered a Stipulation and Order Vacating Permanent Injunction and Dismissing All Claims and Counterclaims with Prejudice in In re: Aflibercept Patent Litigation (MDL No.: 1:24-md-3103). ...
By: Goodwin